Bolt Biotherapeutics, Inc. (BOLT) vs Mangoceuticals, Inc. (MGRX)
A side-by-side comparison of Bolt Biotherapeutics, Inc. and Mangoceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BOLT
Bolt Biotherapeutics, Inc.
$3.51HealthcareDelayed quote: Oct 6, 2026, 2:16 PM EDT
MGRX
Mangoceuticals, Inc.
$0.42HealthcareDelayed quote: Oct 6, 2026, 2:15 PM EDT
Total return — BOLT vs MGRX
growth of $100 · dividends reinvested · last 4yBOLT -87.8% (-40.9%/yr)MGRX -99.3% (-71.1%/yr)BOLT compounded faster over this window
Log scale — wide-divergence pair
BOLT MGRX
BOLT vs MGRX: by the numbers
- •MGRX is the larger company ($7M vs $7M market cap).
- •Both run net losses; BOLT's is the smaller (-611.47% vs -4791.48% net margin).
Metrics side by side
Valuation
| Metric | BOLT | MGRX |
|---|---|---|
| P/S ratio | 1.44 | 22.41 |
| P/B ratio | 0.53 | 0.56 |
Profitability
| Metric | BOLT | MGRX |
|---|---|---|
| Gross margin | 80.62% | 54.43% |
| Operating margin | -450.07% | -4200.46% |
| Net margin | -611.47% | -4791.48% |
| ROE | -227.37% | -120.58% |
| ROIC | -90.17% | -102.91% |
Growth (annualized)
| Metric | BOLT | MGRX |
|---|---|---|
| Total return CAGR (5Y) | -57.61% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.